Literature DB >> 26111641

Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma.

Ming Cai1, Zhiqiang Wang, Jiru Zhang, Huan Zhou, Linfang Jin, Ruizhen Bai, Yuan Weng.   

Abstract

BACKGROUND/AIMS: A disintegrin and metalloprotease (ADAM) 17 has been reported to be implicated in cancer cells invasion. Nevertheless, its potential role in lung adenocarcinoma has not been addressed clearly.
METHODS: RT-PCR and Western blot were used to detect the expression of miR-326 and ADAM17 in lung adenocarcinoma samples (n=73). miR-326 mimics and inhibitor were tansfected in human A549 and SPCA1 cell lines. The transwell assay was used to detect the cell invasive ability. The regulation mechanism was evaluated by luciferase reporter assay. The markers of (epithelial-to-mesenchymal transition) EMT were detected by using Western blot assay.
RESULTS: We found increased expression of ADAM17 in lung adenocarcinoma and cell lines. In vitro, up-regulation of ADAM17 promoted cells invasion, while silencing of ADAM17 inhibited cells invasion. Meanwhile, ADAM17 could affect the markers of EMT. Furthermore, we confirmed that ADAM17 is a target of miR-326, which is involved in EMT and cells invasion.
CONCLUSIONS: These findings revealed that ADAM17, a target of miR-326, promoted EMT-induced cells invasion in lung adenocarcinoma.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26111641     DOI: 10.1159/000430288

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

Review 1.  The role of ADAM17 in tumorigenesis and progression of breast cancer.

Authors:  Hongyu Shen; Liangpeng Li; Siying Zhou; Dandan Yu; Sujin Yang; Xiu Chen; Dandan Wang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Tumour Biol       Date:  2016-09-22

2.  microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.

Authors:  Fei-Fei Wang; Song Wang; Wen-Hua Xue; Jing-Liang Cheng
Journal:  Mol Cell Biochem       Date:  2016-10-21       Impact factor: 3.396

3.  MicroRNA-149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X-linked inhibitor of apoptosis.

Authors:  Lin Sun; Ruixia Zhai; Li Zhang; Shuping Zhao
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

4.  miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.

Authors:  Jipeng Li; Shanfeng Li; Zhe Chen; Jianhua Wang; Ying Chen; Zhengyang Xu; Mingwei Jin; Wanjun Yu
Journal:  Tumour Biol       Date:  2016-07-26

5.  Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.

Authors:  Yuduo Guo; Xin He; Mingshan Zhang; Yanming Qu; Chunyu Gu; Ming Ren; Haoran Wang; Weihai Ning; Junfa Li; Chunjiang Yu; Hongwei Zhang
Journal:  J Neurooncol       Date:  2020-03-13       Impact factor: 4.130

6.  Long non-coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR-326/-330-5p.

Authors:  Peng Song; Shu-Cheng Yin
Journal:  Aging (Albany NY)       Date:  2016-11-03       Impact factor: 5.682

7.  Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer.

Authors:  Wanjun Yu; Hao Jiang; Huihui Zhang; Jipeng Li
Journal:  Onco Targets Ther       Date:  2018-09-07       Impact factor: 4.147

8.  Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.

Authors:  Chengcao Sun; Chuanfeng Huang; Shujun Li; Cuili Yang; Yongyong Xi; Liang Wang; Feng Zhang; Yunfeng Fu; Dejia Li
Journal:  Oncotarget       Date:  2016-02-16

9.  Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.

Authors:  Michael Ruff; Dominique Bonnier; Bassil Dekky; Vincent Legagneux; Nathalie Théret
Journal:  Oncotarget       Date:  2018-04-20

10.  MiR-326/Sp1/KLF3: A novel regulatory axis in lung cancer progression.

Authors:  Rong Wang; Jiali Xu; Jing Xu; Wei Zhu; Tianzhu Qiu; Jun Li; Meiling Zhang; Qianqian Wang; Tongpeng Xu; Renhua Guo; Kaihua Lu; Yongmei Yin; Yanhong Gu; Lingjun Zhu; Puwen Huang; Ping Liu; Lianke Liu; Wei De; Yongqian Shu
Journal:  Cell Prolif       Date:  2018-11-28       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.